Kaiser, Peter K.

Ranibizumab for Neovascular Age-Related Macular Degeneration

Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 5,886

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 3,522

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration

Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 2,485

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 1,318

Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

Schmidt-Erfurth, U., Kaiser, P. K., Korobelnik, J.-F., Brown, D. M., Chong, V., Nguyen, Q. D., Ho, A. C., Ogura, Y., Simader, C., Jaffe, G. J., et al. (2014) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 822

Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results

Kaiser, P. K., Brown, D. M., Zhang, K., Hudson, H. L., Holz, F. G., Shapiro, H., Schneider, S., & Acharya, N. R. (2007) · American Journal of Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 361

Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab

Monés, J., Srivastava, S. K., Jaffe, G. J., Tadayoni, R., Albini, T. A., Kaiser, P. K., Holz, F. G., Korobelnik, J.-F., Kim, I. K., Pruente, C., et al. (2021) · Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 351

Review of gene therapies for age-related macular degeneration

Khanani, A. M., Thomas, M. J., Aziz, A. A., Weng, C. Y., Danzig, C. J., Yiu, G., Kiss, S., Waheed, N. K., & Kaiser, P. K. (2022) · Eye

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 119

Changes in muscle metabolites in females with 30-s exhaustive exercise.

JACOBS, I., BAR-OR, O., KARLSSON, J., DOTAN, R., TESCH, P., KAISER, P., & INBAR, O. (1982) · Medicine & Science in Sports & Exercise

Cardiovascular and exercise physiologySports Performance and Training

Cited by 74

Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis

Parpia, S., Morris, T. P., Phillips, M. R., Wykoff, C. C., Steel, D. H., Thabane, L., Bhandari, M., Chaudhary, V., for the Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group, Sivaprasad, S., et al. (2022) · Eye

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 32

Current best clinical practices—management of neovascular AMD

Brown, D., Heier, J. S., Boyer, D. S., Freund, K. B., Kaiser, P., Kim, J. E., & Sarraf, D. (2017) · Journal of VitreoRetinal Diseases

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 23

Mother, child and adolescent health outcomes in two long-term refugee camp settings at the Thai-Myanmar border 2000–2018: a retrospective analysis

Benner, M. T., Mohr, O., Kaloy, W., Sansoenboon, A., Moungsookjarean, A., Kaiser, P., Carrara, V. I., & McGready, R. (2024) · Primary Health Care Research & Development

Global Maternal and Child HealthMigration, Health and Trauma

Cited by 3